Safecor Health Recalls Metoclopramide Tablets Due to Co-Mingled Tablets
Safecor Health has issued a recall for Metoclopramide Tablets, USP, 5 mg due to co-mingled tablets.
Safecor Health, LLC is voluntarily recalling select batches of Metoclopramide Tablets, USP, 5 mg. The prescription medication is packaged in 100-tablet bottles and manufactured for Teva Pharmaceuticals.
The recall was initiated after reports of a co-mingled tablet in the packaging. The U.S. Food and Drug Administration has designated this action as a Class II recall.
The product was distributed nationwide across the United States.
What to do
- Stop using the affected product immediately.
- Consult your healthcare provider or pharmacist regarding alternative treatment options.
- Contact Safecor Health or the FDA for additional information and instruction.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | D-0075-2027 |
| Date | 2026-11-04 |
| Company | Safecor Health, LLC, Rockford, IL |
| Severity | Class II |
| Where sold | US Nationwide |
| Lot codes / identifiers | Lot # 3116509, Expiry: 07/31/2027. |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.